163 related articles for article (PubMed ID: 37384896)
1. Survival Outcomes and Prognostic Factors of Dermatofibrosarcoma Protuberans: A Population-Based Retrospective Cohort Analysis.
Chen S; Xiong L; Zhao L; Li Y; Li L
Dermatol Surg; 2023 Sep; 49(9):825-831. PubMed ID: 37384896
[TBL] [Abstract][Full Text] [Related]
2. Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?
Huis In 't Veld EA; van Coevorden F; Grünhagen DJ; Smith MJ; van Akkooi ACJ; Wouters MWJM; Hayes AJ; Verhoef C; Strauss DC; van Houdt WJ
Cancer; 2019 Mar; 125(5):735-741. PubMed ID: 30644528
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
[TBL] [Abstract][Full Text] [Related]
4. A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control.
Harati K; Lange K; Goertz O; Lahmer A; Kapalschinski N; Stricker I; Lehnhardt M; Daigeler A
World J Surg Oncol; 2017 Jan; 15(1):5. PubMed ID: 28056985
[TBL] [Abstract][Full Text] [Related]
5. From Morphea to Dermatofibrosarcoma Protuberans.
Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
[TBL] [Abstract][Full Text] [Related]
6. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
[TBL] [Abstract][Full Text] [Related]
7. Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment.
Stojadinovic A; Hoos A; Karpoff HM; Leung DH; Antonescu CR; Brennan MF; Lewis JJ
Arch Surg; 2001 Jan; 136(1):70-9. PubMed ID: 11146782
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological analysis of dermatofibrosarcoma protuberans with long-term follow-up.
Shi X; Tan Q
J Plast Reconstr Aesthet Surg; 2020 Jun; 73(6):1143-1150. PubMed ID: 32201322
[TBL] [Abstract][Full Text] [Related]
9. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.
Gloster HM; Harris KR; Roenigk RK
J Am Acad Dermatol; 1996 Jul; 35(1):82-7. PubMed ID: 8682970
[TBL] [Abstract][Full Text] [Related]
10. Incidence and Survival Outcomes of Dermatofibrosarcoma Protuberans From 2000 to 2020: A Population-Based Retrospective Cohort Analysis.
Xiong DD; Bordeaux JS
Dermatol Surg; 2023 Dec; 49(12):1096-1103. PubMed ID: 37962980
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread.
Ratner D; Thomas CO; Johnson TM; Sondak VK; Hamilton TA; Nelson BR; Swanson NA; Garcia C; Clark RE; Grande DJ
J Am Acad Dermatol; 1997 Oct; 37(4):600-13. PubMed ID: 9344201
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.
Abbott JJ; Oliveira AM; Nascimento AG
Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088
[TBL] [Abstract][Full Text] [Related]
13. Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution.
Jing C; Zhang H; Zhang X; Yu S
Dermatol Surg; 2021 Feb; 47(2):e26-e30. PubMed ID: 32769521
[TBL] [Abstract][Full Text] [Related]
14. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up.
Goldblum JR; Reith JD; Weiss SW
Am J Surg Pathol; 2000 Aug; 24(8):1125-30. PubMed ID: 10935653
[TBL] [Abstract][Full Text] [Related]
15. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
16. Oncological efficiency of wide local excision in dermatofibrosarcoma protuberans.
Güç ZG; Güç H; Bütün O; Alacacıoğlu A; Demirdöver C
J Plast Reconstr Aesthet Surg; 2023 Feb; 77():244-252. PubMed ID: 36592535
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for distant metastasis of dermatofibrosarcoma protuberans.
Hayakawa K; Matsumoto S; Ae K; Tanizawa T; Gokita T; Funauchi Y; Motoi N
J Orthop Traumatol; 2016 Sep; 17(3):261-6. PubMed ID: 27289468
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
19. Outcome After Surgical Treatment of Dermatofibrosarcoma Protuberans (DFSP): Does it Require Extensive Follow-up and What is an Adequate Resection Margin?
Alshaygy I; Mattei JC; Basile G; Griffin AM; Gladdy RA; Swallow CJ; Dickson BC; Wunder JS; Ferguson PC
Ann Surg Oncol; 2023 May; 30(5):3106-3113. PubMed ID: 36658251
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Factors, Treatment, and Survival in Dermatofibrosarcoma Protuberans.
Criscito MC; Martires KJ; Stein JA
JAMA Dermatol; 2016 Dec; 152(12):1365-1371. PubMed ID: 27262160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]